Match Document Document Title
US20130125910 Use of Electrophoretic Microcapsules in a Cosmetic Composition  
Provided are cosmetic compositions incorporating electrophoretic colorants than can effect stable and reversible changes in the color of the cosmetic in response to an electric field. The...
US20130052275 Warming Inch Loss Delivery System  
This invention is a topical treatment for the skin, used for skin enhancement, firming, smoothing, refining and to reduce the appearance of cellulite; that has a self-warming or thermogenic effect...
US20110305642 MICRONUTRIENT SUPPLEMENT  
A micronutrient supplement the supplement being characterized by having at least two types of distinct dosage units wherein said distinct dosage units which physically separate nutritional,...
US20150064244 KONJAC FORMULATION AND METHOD FOR PREPARING THE SAME  
A konjac formulation in the form of a capsule, including between 85 and 95 parts by weight of konjac gum, between 5 and 10 parts by weight of black rice, between 0.5 and 2 parts by weight of...
US20110165233 STABILITY ADDITIVES FOR DRY DHA DOSAGE FORMS  
The use of additives to stabilize DHA when compressed into tablets, or filled as a powder into capsules, for oral administration.
US20120148648 SURFACE MODIFIED PIGMENT  
A composition comprising a pigment particle that is coated with a cationic material and isopropyl titanium triisostearate. The pigment particle can be included in a cleansing composition for...
US20150196471 Multi-Step Product For Improving The Appearance And Feel Of Human Skin  
A multi-layer product for improving the look of human skin by the steps of: apply to the skin a first layer that is a skin care composition; and applying to, and on top of, the first layer, a...
US20140178331 METHOD OF TREATING CEREBRAL HEMORRHAGE AND SUBARACHNOID HEMORRHAGE COMPRISING ADMINISTERING METAL CHELATORS TO THE UPPER ONE-THIRD OF THE NASAL CAVITY  
Methods for preconditioning and/or providing neuroprotection to the animal central nervous system against the effects of cerebral hemorrhage and subarachnoid hemorrhage. Therapeutic agents are...
US20120052135 Phosphate Adsorbent  
Subject of the present invention are compositions comprising a mixture of calcium, magnesium and iron salts for use as a pharmaceutical preparation for adsorbing phosphate, especially for use as...
US20130108709 TREATMENT OF MITOCHONDRIA-RELATED DISEASES AND IMPROVEMENT OF AGE-RELATED METABOLIC DEFICITS  
Pharmaceutical compositions and methods for the treatment of subjects, including humans, who have or are at risk for various disease, disorders and conditions, including, mitochondria-associated...
US20120207809 Method and system for effecting changes in pigmented tissue  
Methods and systems are described for a rapid and sustainable change in the pigment melanin content of melanocytes of the iris stroma, thereby to change the color of the eye. Also described are...
US20110262560 Pigmented Emulsion Makeup Compositions With Gemstones  
A pigmented emulsion composition comprising a water phase, an oil phase, and a plurality of gemstones in particulate form, and a method for providing a glow to the skin and ameliorating the...
US20150147400 SOLID ORAL DOSAGE FORM FOR BREAST SYMPTOMS  
The invention is a solid oral dosage form that is designed to deliver a supraphysiological dose of molecular iodine of 3 to 60 mg per day. The solid oral dosage form is designed to have a low risk...
US20110008407 COATING AND COATING METHOD  
The present invention discloses a coating for a medical implant, wherein at least a part of said coating contains an osseointegration agent and the same and/or a different part of the coating...
US20150150904 DIETARY SUPPLEMENT COMPOSITION AS A PROPHYLACTIC AND TREATMENT FOR SKIN DISEASES SUCH AS ECZEMA AND PSORIASIS AND THE LIKE AND METHOD OF TREATMENT  
A dietary supplement composition as a prophylactic and treatment for skin diseases such as eczema and psoriasis and the like, the composition comprising a phase II liver detoxification component...
US20110027388 Cobalt Hexammine as a Potential Therapeutic Against HIV and/or Ebola Virus  
Hexaamminecobalt(III) chloride, also called Cohex, reduces the extent of viral infection, including difficult to treat infections caused by Ebola virus and HIV. Disclosed are methods for treating...
US20120100223 LIPID-CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF  
Lipid compositions comprising nuts, seeds, oils, legumes, fruits, grains, and dairy useful in specified amounts as dietary supplements and diet plans designed around and including the...
US20110189250 GREEN APPROACH IN METAL NANOPARTICLE-EMBEDDED ANTIMICROBIAL COATINGS FROM VEGETABLE OILS AND OIL-BASED MATERIALS  
The present invention generally relates to a method of making nanoparticles and uses thereof. In particular, the invention relates to methods of making metal nanoparticles (MNPs). The invention...
US20140363520 WET HAND TOWEL AND METHOD FOR PRODUCING THE SAME  
A substrate contains a composition including VOSO4, K11H[(VO)3(SbW9O33)2], Na9[SbW9O33], oxacillin and 5-chloro-2-(2,4-dichlorophenoxy)phenol.
US20130089578 LIQUID INSECTICIDE INCLUDING DIATOMACEOUS EARTH  
An insecticide including diatomaceous earth in a liquid mixture of water and one or more additives is provided. The diatomaceous earth may be present in an amount between at least 20 and less than...
US20120171164 USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN IN SUPPORTING RESISTANCE TO VIRAL RESPIRATORY TRACT INFECTIONS  
The present disclosure relates to the use of nutritional compositions including lactoferrin in supporting resistance to a viral respiratory tract infection. The method includes administering to a...
US20120203147 VASODILATOR-ENHANCED CARDIOPULMONARY RESUSCITATION  
A method for increasing blood flow to vital organs during cardiopulmonary resuscitation of a person experiencing a cardiac arrest may include performing standard or active compression...
US20130052278 QUICK DISSOLVE NUTRITIONAL POWDER  
The present disclosure provides a rapidly disintegrating orally administrable powder. The powder may include an active ingredient such as a dietary supplement. Methods of using the same are also...
US20120308668 MAZINDOL COMBINATION IN THE TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY  
The present invention relates to the field of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered...
US20130078288 Method of Treating Cancer  
A method and composition for administering a therapeutic composition to a lesion comprising about 20% to about 50% ethanol and other novel therapeutic agents.
US20110003013 METHOD OF INCREASING METABOLISM  
The present invention provides a method for increasing metabolism and/or energy expenditure in a subject, e.g., to treat or prevent obesity and/or a related condition and/or to reduce adiposity,...
US20150202224 METHOD OF TREATING IRON DEFICIENCY ANEMIA  
Methods for predicting responsiveness of a subject to iron therapy and treatment methods related thereto. Such methods can be useful with respect to conditions, disorders, or diseases associated...
US20150017260 COMPOSITIONS OF NUTRITION SUPPLEMENTATION FOR NUTRITIONAL DEFICIENCIES AND METHOD OF USE THEREOF  
A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a...
US20110223260 Mazindol Combindation In The Treatment Of Attention Deficit/Hyperactivity  
The present invention relates to the filed of human health, and more particularly to the treatment of attention deficit/hyperactivity disorder (ADHD) with mazindol. The latter can be administered...
US20150017261 Methods of Treating and Preventing Cancer by Disrupting the Binding of Copper in the Map Kinase Pathway  
The present disclosure provides methods of treating and/or preventing cancer in a subject comprising administering to the subject a copper-reduced diet by itself or as a supplement along with a...
US20140212508 COPPER/ZINC SUPEROXIDE DISMUTASE (SOD) FORMULATION FOR THE TREATMENT OF TRAUMAS INCLUDING AMYOTROPIC LATERAL SCLEROSIS  
A Copper/Zinc superoxide dismutase (Cu/Zn SOD) composition comprising a therapeutically effective amount of ionic mineral(s) in a ligand complex and a pharmaceutically acceptable carrier for the...
US20110280927 COMPOSITION AND DRESSING WITH NITRIC OXIDE  
A dressing composition for use as a skin dressing comprises an elastomeric-adhesive composition, and a zeolite comprising releasably adsorbed nitric oxide. The zeolite may comprise a transition...
US20150147392 HEMOSTATIC DEVICE AND METHOD  
A method of arresting blood flow from a bleeding wound including the steps of (1) providing a solid hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin...
US20140330221 Hemostatic device and method  
A hemostatic tablet preferably including potassium ferrate and a cation ion exchange resin pressure formed into a tablet for delivery to a bleeding wound. The tablet improves the rate of adhesion...
US20120207802 Pigment Mixtures for Cosmetics  
Provided is a pigment composition comprising a first and second effect pigments, wherein the composition has a hue comparable to carmine but does not comprise carmine.
US20130115262 SUBSTRATE HAVING AN ELECTRON DONATING SURFACE WITH METAL PARTICLES COMPRISING PALLADIUM ON SAID SURFACE  
A substrate with an electron donating surface, characterized in having metal particles on said surface, said metal particles having palladium and at least one metal selected from gold, ruthenium,...
US20110244057 COMBINATION THERAPIES WITH TOPIRAMATE FOR SEIZURES, RESTLESS LEGS SYNDROME, AND OTHER NEUROLOGICAL CONDITIONS  
The invention provides compositions and methods of treating various conditions, including neurological conditions, with pharmaceutical compositions including a sulfamate (e.g., topiramate) and...
US20140141052 SUBSTRATE HAVING AN ELECTRON DONATING SURFACE WITH METAL PARTICLES COMPRISING PALLADIUM ON SAID SURFACE  
There is disclosed a substrate with an electron donating surface, characterized in having metal particles on said surface, said metal particles comprising palladium and at least one metal selected...
US20080118452 Cosmetic Comprising Multi-Colored Lustrous Pearlescent Pigments  
A cosmetic containing a pearlescent pigment comprising a substrate and a first layer, wherein the first layer comprises iron oxide, wherein the iron has from about 1% to about 30% Fe(II) and from...
US20120302819 TREATMENT OF CANCER OR TUMORS INDUCED BY THE RELEASE OF HEAT GENERATED BY VARIOUS CHAINS OF MAGNETOSOMES EXTRACTED FROM MAGNETOTACTIC BACTERIA AND SUBMITTED TO AN ALTERNATIVE MAGNETIC FIELD  
In this disclosure, we describe a method for the treatment of tumor(s) or tumor cell(s) or cancer(s) in a subject in need by the generation of heat. The latter is produced by chains of...
US20130202696 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20130344113 Iron Fortified Food Product and Additive  
The present invention relates to a food product which has been fortified in iron content, comprising a Fe3O4 sphere. The present invention also relates to an iron-containing additive for use in...
US20140147514 EXTRACTION OF VITAMINS AND MINERALS FROM PLANT MATTER  
A process for extracting vitamins and minerals from a first plant matter(s) is disclosed wherein the said first plant matter(s) is treated with acidic matter followed by extraction with water....
US20110183006 COMPOSITIONS AND METHODS FOR TREATING OSTEOARTHRITIS  
The present invention provides compositions and methods for treatment of abnormal conditions in a subject, wherein the abnormal condition affects the musculoskeletal joints of the subject.
US20130295022 Moisturizing Foam Containing Lanolin  
The present invention provides a highly tolerable, hydrating lanolin containing foamable composition for administration to the skin, body surface, body cavity or mucosal surface, e.g., the mucosa...
US20130202694 Agent for use in the case of fructose intolerance  
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose...
US20130149539 TUNED MULTIFUNCTIONAL MAGNETIC NANOPARTICLES FOR BIOMEDICINE  
Magnetic nanoparticles and related devices and methods are described. Compositions and methods can include magnetic nanoparticles having a narrow size distribution for use in diagnostics and...
US20140302154 MAGNETIC TRANSDUCERS  
Embodiments herein relate to the production of biocompatible magnetic nanoparticles with a high SAR-value which produce a large amount of heat when exposed to an alternating magnetic field. The...
US20110052609 MAGNETIC TRANSDUCERS  
Embodiments herein relate to the production of biocompatible magnetic nanoparticles with a high SAR-value which produce a large amount of heat when exposed to an alternating magnetic field. The...
US20120195976 METHODS OF TREATING INFLAMMATION BY ADMINISTRATION OF HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION  
The present invention relates to the treatment of disorders using heme oxygenase-1 and heme degradation products.